Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

TOMI Environmental Solutions, Inc. Announces East Coast Operations Office Move to New Larger Space


Posted on: 07 May 18

BEVERLY HILLS, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including SteraMist™, a hydrogen peroxide-based mist and fog registered as Binary Ionization Technolgy® (BIT™) with the U.S. Environmental Protection Agency (“EPA”) for use as a hospital-healthcare disinfectant, and general disinfectant, including C. diff, h1n1, norovirus, salmonella and MRSA, announced today that its East Coast Operations Office will move to larger space in Frederick, MD.

The company, is currently located in approximately a 5,000 square foot facility and has outgrown the exisiting space requiring a larger facility to accommodate the expansion of its sales teams, as well as allowing for additional hires across all departments, including our new Customer Service department.

A larger warehouse space will be allocated exclusively to inventory and additional new products and equipment that the company has acquired and sells, on-site testing and training, and a research & development innovation lab. The new facility will feature a one-of-a-kind, state-of-the-art built-in decontamination chamber to demonstrate the ease, quickness and effectiveness of the Company’s core product “SteraMist” while everyday applying it to all types of vehicles from the neighboring communities.

The new facility, is more than 9,000 square feet, and almost doubles our operations space. It will be located at Riverside Corporate Park in the heart of emerging bio-tech companies and research centers. This location is ideal due to its accessibility and easy access to the Greater Baltimore and Washington DC / Route 270 corridors.

Dr. Halden Shane, TOMI CEO, believes this move to be a strong indication of TOMI’s commitment to growth and expanding the SteraMist™ brand. “Our current space has allowed us to get our operations team and processes in place. But we have simply outgrown the space. The new facility will allow us the opportunity to provide an even higher level of customer service support to current and future clients, training on SteraMist™ products, and to explore additional ways to continue to innovate our world-class innovative technology”.

About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense. BIT™ uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (OH ion), represented by the TOMI™ SteraMist™ brand of products, which produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI’s products are designed to service a broad spectrum of commercial structures including but not limited to hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release

MEDIA RELATIONS CONTACT
Juliana deRosa
Executive Administrator
jderosa@tomimist.com

GlobeNewswire
globenewswire.com

Last updated on: 07/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.